Skip to content

Human & Experimental Toxicology

ISSN 0960-3271

6 papers in the library · 234 citations · publishing 1999-2025

Papers

Sort Most recent Most cited

Insights into therapeutic potential and practical applications of natural toxins from poisonous mushrooms

Human & Experimental Toxicology March 11, 2025 Tharuka Wijesekara, Baojun Xu 5 citations

Introduction Mushrooms, belonging to the phyla Ascomycota and Basidiomycota, comprise approximately 14,000 known species, among which a small fraction are toxic. While toxic mushrooms are primarily associated with adverse health effects, recent research highlights their potential as sources of bioactive compounds with promising therapeutic applications. Methods A systematic review was conducted...

DOI: 10.1177/09603271251323134 (opens in new tab) Psilocybin Mushroom Pharmacology Traditional medicine

RETRACTED: Long-term systemic treatment with lysergic acid diethylamide causes retinal damage in CD1 mice

Human & Experimental Toxicology November 25, 2018 H. Jiang, H. Xu Retracted

As a classical hallucinogen with high potential for abuse, lysergic acid diethylamide (LSD) can cause long-lasting abnormalities in retina, but little is known about the exact mechanism. This study was to investigate effects of long-term systemic treatment of LSD at low dose on retinal damage and understand the underlying mechanisms. CD1 mice were treated intraperitoneally with 0.1 mg/kg or 0.2...

Morbidity associated with MDMA (ecstasy) abuse: A survey of emergency department admissions

Human & Experimental Toxicology May 20, 2010 Pinchas Halpern, Jenny Moskovich, Beni Avrahami et al. 54 citations

Methods: We conducted a prospective, representative-sample nationwide study on morbidity related to 3,4, methylenedioxymethamphetamine (MDMA; ‘ecstasy’) as determined from admissions to 5 geographically representative emergency departments (EDs) and from data from the poison information center (PIC). MDMArelated ED admissions were analyzed over a 7-month period and the records of all PIC calls...

DOI: 10.1177/0960327110370984 (opens in new tab) Ecstasy MDMA Emergency department Emergency medicine +4

Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review.

Human & Experimental Toxicology March 1, 2008 R Maciulaitis, Violeta Kontrimaviciūte, Françoise M M Bressolle et al. 102 citations

Ibogaine is an indole alkaloid derived from the bark of the root of the African shrub Tabernanthe iboga. Psychoactive properties of ibogaine have been known for decades. More recently, based on experimental data from animals and anectodal reports in human, it has been found that this drug has anti-addictive effects. Several patents were published between 1969 and 1995. The pharmacology of...

DOI: 10.1177/0960327107087802 (opens in new tab) Full text (opens in new tab) Noribogaine Natural compound African shrub compound Addiction treatment +10

The acute effects of tetrahydrocannabinol on auditory threshold and frequency resolution in human subjects.

Human & Experimental Toxicology June 2002 M Mulheran, P Middleton, J A Henry

The study was designed to investigate the acute effects of ingested tetrahydrocannabinol (THC) on auditory function. Eight male subjects (aged 22-30 years), who had previous experience of cannabis use, took part in this study. They performed air conduction pure tone audiometry in both ears over 0.5-8 kHz. A simple test of frequency selectivity by detecting a 4-kHz tone under two masking noise...

Fatal multi-organ failure after suicidal overdose with MDMA, `Ecstasy': case report and review of the literature

Human & Experimental Toxicology February 1, 1999 Andrew Walubo, Donna Seger 73 citations

A 53-year-old prisoner died of multiorgan failure after a suicidal overdose with 3,4-methylenedeoxymethamphe-tamine (MDMA, `Ecstasy'). Twelve hours after ingestion of MDMA, the patient became severely hyperthermic (107.2°F) with evidence of rhabdomyolysis. He subsequently developed acute respiratory distress syndrome (ARDS), disseminated intravascular coagulopathy (DIC) and acute renal failure....